AgeX Therapeutics, Inc. (AGE)

Cash & Short-Term Investments

$23.02M

Quarterly · Period ending: · USD

AGE logo

AGE Cash & Short-Term Investments

Latest reported$23.02M
AGE Quarterly Cash & Short-Term Investments ($11.36M → $23.02M)
High-resolution chart · PNG

AGE cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

AgeX Therapeutics, Inc. Cash & Short-Term Investments — Quarterly (USD)
Period endingCash & Short-Term Investments (USD)
23,024,000
24,526,000
3,056,000
8,620,000
6,041,000
4,267,000
3,672,000
3,185,000
6,064,000
8,706,000
345,000
397,000
261,000
280,000
645,000
466,000
702,000
448,000
584,000
731,000
615,000
809,000
527,000
1,107,000
1,033,000
468,000
2,352,000
3,768,000
5,813,000
8,586,000
6,707,000
8,756,000
11,360,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.